Latest Divestitures News

International Flavors & Fragrances raised the lower end of its 2026 sales and adjusted EBITDA guidance after broad-based third-quarter growth. The stronger operating result sits alongside a US$134 million pre-tax continuing-operations loss and a costly Food Ingredients separation still awaiting completion.

Revvity has lifted its full-year 2026 outlook after reporting stronger third-quarter revenue, organic growth and profitability. The life sciences and diagnostics group is also preparing to sell its China immunodiagnostics business for up to US$200 million.

Eaton delivered record third-quarter sales, margins and orders, then raised its full-year 2026 organic growth guidance to 13% to 15%. The power-management group is also adding another European electrical acquisition while preparing to separate its Mobility business.

Yum! Brands has completed its Pizza Hut exit, lifting third-quarter GAAP earnings with a US$1.7 billion pretax gain. Beneath that windfall, KFC delivered strong expansion while Taco Bell's US sales weakened sharply.

Marathon Petroleum reported a sharp third-quarter earnings increase, powered by much stronger refining margins and full refinery utilisation. The company also lifted its dividend, added US$5 billion to its buyback authorisation and agreed to sell two refineries for US$4.2 billion.

Gartner delivered stronger adjusted earnings and cash flow in the third quarter, while contract value growth accelerated and management raised its full-year 2026 outlook. The headline GAAP revenue decline was distorted by the sale of its Digital Markets operation.

ResMed has delivered a stronger first quarter for fiscal 2027, with revenue up 6% to US$1.415 billion and net income rising 20% to US$418 million. The headline result was helped by a preliminary gain on the MatrixCare sale, while the core Sleep and Breathing Health business continued to expand.

James Hardie has raised its FY27 Free Cash Flow target to at least US$600 million and expects to deliver its US$125 million cost synergy target roughly a year early. The company also outlined a 4% to 7% annual organic growth ambition above market, while targeting net leverage below 2.0x by Q2 FY28.

NOVONIX Limited posted a $24.6 million half-year loss while delivering a critical synthetic graphite sample to Panasonic and reaffirming a 2027 production start. The company raised $21.7 million to fund its North American battery materials expansion amid ongoing U.S. trade and policy developments.

James Hardie Industries has agreed to divest its European Fermacell sustainable walling and flooring business to Holcim for €840 million, while planning to close its European fiber cement operations and launch a $250 million share buyback.

ResMed Inc. posted a 10% rise in fiscal 2026 revenue to $5.65 billion, bolstered by the acquisition of Noctrix Health and an agreement to sell its MatrixCare business. The company continues to invest in AI-powered digital health solutions amid ongoing patent litigation and a shifting regulatory landscape.

Amcor’s FY 2026 results highlight a dramatic boost from the Berry acquisition, with net sales soaring 57% to $23.5 billion and adjusted EBITDA up 68%. The company also raised its quarterly dividend and outlined a transition to a December year-end.